A multicenter, randomized, double blinded, parallel-group, placebo controlled study to assess the efficacy and safety of skeletal muscle-derived cell implantation in female patients with stress urinary incontinence

Trial Profile

A multicenter, randomized, double blinded, parallel-group, placebo controlled study to assess the efficacy and safety of skeletal muscle-derived cell implantation in female patients with stress urinary incontinence

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2016

At a glance

  • Drugs ICES 13 (Primary)
  • Indications Stress incontinence
  • Focus Registrational; Therapeutic Use
  • Acronyms Innovation
  • Sponsors Innovacell Biotechnologie GmbH
  • Most Recent Events

    • 12 Dec 2015 Status changed from recruiting to completed, according to European Clinical Trials Database
    • 28 Sep 2015 EudraCT reports planned patient no as 369 in Czech Republic.
    • 21 Apr 2015 New source identified and integrated: European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top